Adamas Pharmaceuticals, Inc. Aktie

Aktier

2021-08-09	Adamas Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 09, 2021
2021-05-11	Adamas Pharmaceuticals, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-11-2021 11:45 AM
2021-05-10	Adamas Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 10, 2021
2021-03-02	Adamas Pharmaceuticals, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 02:50 PM
2021-02-23	Adamas Pharmaceuticals, Inc., Q4 2020 Earnings Call, Feb 23, 2021
2021-02-01	Adamas Pharmaceuticals, Inc. - Special Call
2021-01-11	Adamas Pharmaceuticals, Inc. Presents at H.C. Wainwright BioConnect 2021 Conference, Jan-11-2021 06:00 AM
2020-11-05	Adamas Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 05, 2020
2020-08-06	Adamas Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 06, 2020
2020-05-07	Adamas Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 07, 2020
2020-02-25	Adamas Pharmaceuticals, Inc., Q4 2019 Earnings Call, Feb 25, 2020
2019-11-07	Adamas Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 07, 2019
2019-08-08	Adamas Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 08, 2019

2021-11-24	Adamas Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K
2021-11-24	ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
2021-11-24	Adamas Pharmaceuticals, Inc. Announces Management Changes
2021-11-24	Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from NASDAQ Composite Index
2021-11-24	Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P TMI Index

1 dag

+0,74 %

Verkställande direktör	Titel	Ålder	Sedan
Jack Khattar PSD	President	64	2021-11-24

Styrelseledamot	Titel	Ålder	Sedan
Bryan Roecklein BRD	Direktör/Styrelseledamot	-	2021-11-24
Jack Khattar BRD	Direktör/Styrelseledamot	64	2021-11-24

Datum	Insider	Typ	Huvudposition	Kvantitet	% av börsvärdet.
21-11-24	Michael Bigham	Tender	Styrelseledamot	40 000	0,0875%
21-11-24	Vijay Shreedhar	Kostnadsfri	Chef / ledande befattningshavare	390 536	0,8547%
21-11-24	MDV Management Co. LLC	Tender	Företag	4 619 796	10,1111%

Lägg till i en lista 0 vald För att använda denna funktion måste du vara en kund eller medlem Logga in Registrera dig	Förändring	Utveckling 5 d	Varia. 1 år	Föränd. 3 år	Kapi.($)
ADAMAS PHARMACEUTICALS, INC.	+0,74 %	+0,24 %	-	-	376 mn
LONZA GROUP AG	+0,80 %	−1,09 %	+3,16 %	+17,38 %	49,74 md
REVOLUTION MEDICINES, INC.	+2,09 %	−0,71 %	+452,73 %	+498,77 %	44,98 md
IQVIA HOLDINGS INC.	−1,09 %	−0,41 %	+35,40 %	+15,17 %	42,52 md
BEONE MEDICINES AG	−0,26 %	−4,71 %	+17,19 %	+71,67 %	40,78 md
CELLTRION, INC.	−0,48 %	−0,84 %	+16,25 %	+49,80 %	32,89 md
ASCENDIS PHARMA A/S	−1,06 %	+2,87 %	-	-	17,09 md
MEDPACE HOLDINGS, INC.	−1,81 %	−5,02 %	+22,65 %	+113,24 %	16,28 md
EUROFINS SCIENTIFIC SE	+0,84 %	−0,93 %	+17,49 %	+26,96 %	14,4 md
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	−2,05 %	−5,14 %	+72,89 %	+34,69 %	13,48 md
Genomsnitt	−0,10 %	−2,44 %	+79,72 %	+103,46 %	30,24 md
Viktad genomsnitt av Capi.	+0,18 %	−2,27 %	+97,49 %	+122,34 %